Skip to search formSkip to main contentSkip to account menu

Ixoten

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
SummaryUrotoxic side effects, especially hemorrhagic cystitis, have so far been a limiting factor in the therapeutic use of… 
2004
2004
Trofosfamide (Ixoten; Baxter Oncology, Germany) is an alkylating agent that, as with other oxazaphosphorine derivatives, has to… 
1997
1997
GOALS OF WORK There is a need for an effective and nontoxic chemotherapy for palliative indication in non-Hodgkin's lymphoma (NHL… 
1986
1986
Comparison of pharmacological properties of commercial, racemic trofosfamide (Ixoten) and its dextrorotatory and levorotatory… 
1979
1979
Clinical experience with Ixoten (trofosfamide), a derivative of cyclophosphamide, is reported in 29 patients with malignant… 
1979
1979
In an open multicenter phase III trial, prophylaxis of the urinary tract with sodium 2-mercaptoethanesulfonate (Mesnum) was… 
1978
1978
The efficacy of trofosfamide (Ixoten; Noristan), a derivative of cyclophosphamide, was investigated in 76 patients. Those with… 
1975
1975
Cytostatic therapy under conditions of "partial synchronisation" is reported. 12 patients with extensive metastases of malignant…